PMVP Offering: a positive outcome, +6.6%

On September 1, 2026, PMV Pharmaceuticals, Inc. reached its Offering. The result was a positive outcome, and the stock moved +6.6% in the window around the event. It had already run +9.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.